TScan Therapeutics Cash Flow Statement (2020-2026) | TCRX

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-32.91M-25.29M-16.32M-16.16M-15.10M-16.25M-19.55M-22.56M-24.05M-23.00M-25.25M-30.14M-31.66M-29.89M-46.73M-36.98M-36.95M-35.71M-32.19M-28.67M
Depreciation and Depletion (Quarter)
0.66M1.06M1.14M1.20M1.21M1.25M1.48M1.50M1.30M1.29M1.28M1.25M1.12M1.03M0.71M0.68M0.70M0.77M0.72M0.69M
Share-based Compensation (Quarter)
0.50M10.60M0.78M0.98M1.02M1.25M1.30M1.15M1.22M1.34M1.50M1.98M2.33M2.52M2.71M3.41M3.27M3.01M2.01M2.46M
Cash from Operations (Quarter)
-10.70M-13.64M-14.38M-20.12M-13.37M-17.00M-16.01M-23.59M-22.02M8.02M-23.77M-29.27M-26.23M-27.92M-27.41M-37.59M-33.27M-32.46M-32.00M-24.28M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.66M1.06M1.14M1.20M1.21M1.25M1.48M1.50M1.30M1.29M1.28M1.25M1.12M1.03M0.71M0.68M0.70M0.77M0.72M0.69M
Change in Working Capital
Change in Account Payables (Quarter)
1.43M0.88M-2.46M0.82M0.41M-1.12M0.41M0.49M0.37M-0.27M-0.64M-0.41M0.40M1.02M0.98M0.56M-0.43M1.93M-5.07M1.04M
Change in Accured Expenses (Quarter)
0.73M1.71M1.85M-2.80M0.61M1.60M1.32M0.74M0.78M1.02M1.31M-1.60M1.95M0.53M3.66M-5.41M2.67M-1.11M-3.38M0.90M
Other Working Capital Changes (Quarter)
1.50M0.82M-0.44M0.66M-1.15M0.73M0.17M1.18M-2.91M0.69M0.05M-0.26M0.01M1.17M-0.39M0.52M-0.04M-0.87M0.90M-0.13M
Investing Activities
Capital Expenditures (Quarter)
-1.46M7.35M2.21M0.53M1.89M-1.85M-0.13M0.02M0.06M0.26M-0.04M0.70M0.86M1.37M0.89M1.53M-0.60M-0.88M-0.04M0.07M
Change in Acquisitions & Divestments (Quarter)
45.65M15.50M56.00M75.51M76.00M76.25M34.00M15.00M
Cash from Investing Activities (Quarter)
-3.92M-0.85M-2.21M-0.53M-1.89M-0.42M-1.38M-0.84M-0.42M-61.41M1.91M36.16M-33.72M-82.35M27.29M13.53M48.44M32.58M14.83M-0.07M
Financing Activities
Other financing activities (Quarter)
0.06M0.00M0.12M0.09M0.03M0.01M0.07M-0.08M-91.61M0.26M0.18M127.83M-126.56M0.12M0.07M-0.01M0.01M
Cash from Financing Activities (Quarter)
-0.69M90.61M0.12M0.09M0.03M29.13M0.11M-0.25M0.02M0.26M161.59M1.23M45.69M-0.53M0.12M0.07M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.19M-0.19M
Additional items
Change in Cash (Quarter)
-15.30M76.11M-16.47M-20.57M-15.23M11.70M-17.28M-24.43M113.23M-53.65M-21.83M7.15M101.65M-109.04M45.57M-24.58M15.29M0.11M-17.10M-24.35M
Free Cash Flow (Quarter)
-9.24M-20.99M-16.59M-20.66M-15.26M-15.15M-15.88M-23.61M-22.09M7.76M-23.72M-29.97M-27.09M-29.29M-28.30M-39.12M-32.66M-31.59M-31.96M-24.35M
Net Cash Flow (Quarter)
-15.30M76.11M-16.47M-20.57M-15.23M11.70M-17.28M-24.43M-22.44M-53.65M-21.83M7.15M101.65M-109.04M45.57M-24.58M15.29M0.11M-17.10M-24.35M